Literature DB >> 29730714

Health status among long-term breast cancer survivors suffering from higher levels of fatigue: a cross-sectional study.

Francisco Álvarez-Salvago1, Noelia Galiano-Castillo2,3,4, Manuel Arroyo-Morales1,5,6, Mayra Cruz-Fernández1, Mario Lozano-Lozano1,5, Irene Cantarero-Villanueva1,5,6.   

Abstract

PURPOSE: The aims of this study were to evaluate the health status of long-term breast cancer survivors (LTBCS) suffering from higher levels of fatigue, to highlight their needs, and to establish the key points of intervention support programs.
METHODS: A cross-sectional observational study was conducted at the Sport and Health Joint University Institute (iMUDS) between September 2016 and July 2017 with 80 LTBCS that were classified into non-fatigued (≤ 3.9) or fatigued (≥ 4) according to the Piper Fatigue Scale (PFS) total score. The instruments used were the European Organization for Research and Treatment of Cancer Core 30 and its breast cancer (BC) module, the Visual Analog Scale (VAS), the Brief Pain Inventory (BPI), the Scale for Mood Assessment (EVEA), the International Fitness Scale (IFIS), and the Charlson Comorbidity Index.
RESULTS: The analysis revealed that 41.2% of LTBCS were considered moderately fatigued and showed significantly higher levels for the categories of "nausea and vomiting" (P = .005), "pain," "dyspnea" and "insomnia" (P < .001), "appetite loss" (P = .002), "financial difficulties" (P = .010), "systemic therapy side effects" (P < .001), "breast symptoms" and "arm symptoms" (P = .002), and "upset by hair loss" (P = .016). In addition, LTBCS presented significantly higher levels of pain in the affected and non-affected arm, "sadness-depression." "anxiety," "anger/hostility" (All: P < .001), and lower general physical fitness (P < .001). The rest of the variables did not show significant differences.
CONCLUSION: LTBCS suffering from higher levels of fatigue had lower QoL, higher level of pain, worse mood state, and lower physical fitness.

Entities:  

Keywords:  Breast cancer; Fatigue; Long-term survivorship; Quality of life

Mesh:

Year:  2018        PMID: 29730714     DOI: 10.1007/s00520-018-4240-z

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  41 in total

1.  Reliability of the visual analog scale for measurement of acute pain.

Authors:  P E Bijur; W Silver; E J Gallagher
Journal:  Acad Emerg Med       Date:  2001-12       Impact factor: 3.451

2.  Fatigue and quality of life in breast cancer survivors: temporal courses and long-term pattern.

Authors:  Martina E Schmidt; Jenny Chang-Claude; Alina Vrieling; Judith Heinz; Dieter Flesch-Janys; Karen Steindorf
Journal:  J Cancer Surviv       Date:  2011-12-11       Impact factor: 4.442

3.  The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study.

Authors:  M A Sprangers; M Groenvold; J I Arraras; J Franklin; A te Velde; M Muller; L Franzini; A Williams; H C de Haes; P Hopwood; A Cull; N K Aaronson
Journal:  J Clin Oncol       Date:  1996-10       Impact factor: 44.544

Review 4.  Cancer-related fatigue: the scale of the problem.

Authors:  Maarten Hofman; Julie L Ryan; Colmar D Figueroa-Moseley; Pascal Jean-Pierre; Gary R Morrow
Journal:  Oncologist       Date:  2007

5.  Polymorphisms in Cytokine Genes Are Associated With Higher Levels of Fatigue and Lower Levels of Energy in Women After Breast Cancer Surgery.

Authors:  Kord M Kober; Betty Smoot; Steven M Paul; Bruce A Cooper; Jon D Levine; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2016-09-21       Impact factor: 3.612

6.  Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life.

Authors:  Soo Hyun Kim; Byung Ho Son; Sook Yeon Hwang; Wonshik Han; Jung-Hyun Yang; Seeyoun Lee; Young Ho Yun
Journal:  J Pain Symptom Manage       Date:  2008-03-20       Impact factor: 3.612

7.  Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report.

Authors:  Kathleen Meeske; Ashley Wilder Smith; Catherine M Alfano; Bonnie A McGregor; Anne McTiernan; Kathy B Baumgartner; Kathleen E Malone; Bryce B Reeve; Rachel Ballard-Barbash; Leslie Bernstein
Journal:  Qual Life Res       Date:  2007-04-25       Impact factor: 4.147

8.  Long-term physical activity trends in breast cancer survivors.

Authors:  Caitlin Mason; Catherine M Alfano; Ashley Wilder Smith; Ching-Yun Wang; Marian L Neuhouser; Catherine Duggan; Leslie Bernstein; Kathy B Baumgartner; Richard N Baumgartner; Rachel Ballard-Barbash; Anne McTiernan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04-10       Impact factor: 4.254

9.  Assessment of clinical relevant fatigue level in cancer.

Authors:  Yoon Jung Chang; Jung Suk Lee; Chang Geol Lee; Won Sup Lee; Keun Seok Lee; Soo-Mee Bang; Xin Shelley Wang; Tito R Mendoza; Charles S Cleeland; Young Ho Yun
Journal:  Support Care Cancer       Date:  2007-07       Impact factor: 3.359

10.  Predictors and course of chronic fatigue in long-term breast cancer survivors.

Authors:  Kristin Valborg Reinertsen; Milada Cvancarova; Jon H Loge; Hege Edvardsen; Erik Wist; Sophie D Fosså
Journal:  J Cancer Surviv       Date:  2010-09-23       Impact factor: 4.442

View more
  2 in total

1.  Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer.

Authors:  Yosef Landman; Salomon Marcello Stemmer; Aaron Sulkes; Victoria Neiman; Tal Granot; Daniel Hendler; Mordechai Reuven Kramer; Karen Gelmon; Rinat Yerushalmi
Journal:  J Oncol       Date:  2019-10-28       Impact factor: 4.375

2.  Characterizing Breakthrough Cancer Pain Using Ecological Momentary Assessment with a Smartphone App: Feasibility and Clinical Findings.

Authors:  Francisco Villegas; Verónica Martínez-Borba; Carlos Suso-Ribera; Diana Castilla; Irene Zaragoza; Azucena García-Palacios; Carlos Ferrer
Journal:  Int J Environ Res Public Health       Date:  2021-06-03       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.